120 related articles for article (PubMed ID: 9081554)
21. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
22. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
Bürgi U; Gerber H; Peter HJ
Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center.
Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L
J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569
[TBL] [Abstract][Full Text] [Related]
24. Psychiatric and neuropsychological response to propranolol in Graves' disease.
Trzepacz PT; McCue M; Klein I; Greenhouse J; Levey GS
Biol Psychiatry; 1988 Apr; 23(7):678-88. PubMed ID: 3370265
[TBL] [Abstract][Full Text] [Related]
25. Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy.
Elbers L; Mourits M; Wiersinga W
Thyroid; 2011 Mar; 21(3):279-83. PubMed ID: 21190446
[TBL] [Abstract][Full Text] [Related]
26. Progressive systemic sclerosis and Graves' disease. Report of three cases.
Nicholson D; White S; Lipson A; Jacobs RP; Borenstein DG
Arch Intern Med; 1986 Dec; 146(12):2350-2. PubMed ID: 3778068
[TBL] [Abstract][Full Text] [Related]
27. Structural brain changes in hyperthyroid Graves' disease: protocol for an ongoing longitudinal, case-controlled study in Göteborg, Sweden-the CogThy project.
Holmberg MO; Malmgren H; Berglund P; Bunketorp-Käll L; Heckemann RA; Johansson B; Klasson N; Olsson E; Skau S; Nystrom Filipsson H
BMJ Open; 2019 Nov; 9(11):e031168. PubMed ID: 31685507
[TBL] [Abstract][Full Text] [Related]
28. The possible etiological role of psychological disturbances in Graves' disease.
Harsch I; Paschke R; Usadel KH
Acta Med Austriaca; 1992; 19 Suppl 1():62-5. PubMed ID: 1519457
[TBL] [Abstract][Full Text] [Related]
29. [Disorders of concentration and memory in young adults and middle-aged persons].
Verduyn TJ; Blok A; Vergouwen AC; Weinstein HC
Ned Tijdschr Geneeskd; 2005 Mar; 149(13):673-6. PubMed ID: 15819129
[TBL] [Abstract][Full Text] [Related]
30. Ophthalmic Graves' disease.
Mornex R; Fournier G; Berthezene F
Mod Probl Ophthalmol; 1975; 14():426-31. PubMed ID: 1242209
[TBL] [Abstract][Full Text] [Related]
31. Graves' disease with functioning nodules (Marine-Lenhart syndrome).
Charkes ND
J Nucl Med; 1972 Dec; 13(12):885-92. PubMed ID: 4678244
[No Abstract] [Full Text] [Related]
32. Evaluation of early (5 to 6 hours) iodine 123 uptake for diagnosis and treatment planning in Graves' disease.
Hennessey JV; Berg LA; Ibrahim MA; Markert RJ
Arch Intern Med; 1995 Mar; 155(6):621-4. PubMed ID: 7887758
[TBL] [Abstract][Full Text] [Related]
33. [Hyperthyroidism--differential diagnosis and differential therapy].
Henzen Ch
Praxis (Bern 1994); 2003 Jan; 92(1-2):18-24. PubMed ID: 12577605
[TBL] [Abstract][Full Text] [Related]
34. Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Laurberg P; Berman DC; Andersen S; Bülow Pedersen I
Thyroid; 2011 Sep; 21(9):951-6. PubMed ID: 21834677
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
36. [Euthroid Graves' disease].
Pittman JA; Smitherman TC; Harben GA
Cas Lek Cesk; 1968; 107(38):1161-5. PubMed ID: 4176202
[No Abstract] [Full Text] [Related]
37. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
Roti E; Minelli R; Gardini E; Bianconi L; Salvi M; Gavaruzzi G; Ugolotti G; Braverman LE
J Clin Endocrinol Metab; 1994 Mar; 78(3):795-9. PubMed ID: 8126159
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
[TBL] [Abstract][Full Text] [Related]
39. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
40. Psychiatric presentations of hyperthyroidism.
McGaffee J; Lippmann S; Barnes MA
Am Fam Physician; 1983 Feb; 27(2):257-60. PubMed ID: 6687506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
